Ovid Stock Upswing: Better Biotech Growth Signals
When people talk about new opportunities in biotech, Ovid stock upswing needs to be part of the conversation. Right out of the gate, Ovid Therapeutics (NASDAQ: OVID) is showing signs of becoming one of 2025’s quiet breakout stories — and it’s happening for better reasons than just hype. I’ve been watching this closely, and honestly,…